ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SN. Smith & Nephew Plc

978.80
-3.80 (-0.39%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Smith & Nephew Plc LSE:SN. London Ordinary Share GB0009223206 ORD USD0.20
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.80 -0.39% 978.80 975.80 976.20 983.80 967.80 975.60 3,092,529 16:35:08
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Ortho,prosth,surg Appl,suply 5.55B 263M 0.3011 32.41 8.52B
Smith & Nephew Plc is listed in the Ortho,prosth,surg Appl,suply sector of the London Stock Exchange with ticker SN.. The last closing price for Smith & Nephew was 982.60p. Over the last year, Smith & Nephew shares have traded in a share price range of 887.00p to 1,269.00p.

Smith & Nephew currently has 873,398,889 shares in issue. The market capitalisation of Smith & Nephew is £8.52 billion. Smith & Nephew has a price to earnings ratio (PE ratio) of 32.41.

Smith & Nephew Share Discussion Threads

Showing 1151 to 1175 of 1325 messages
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older
DateSubjectAuthorDiscuss
06/9/2022
08:48
unless share price were to move up 10% or more then v v unlikely any rns. in any case i think its a passive stake build. any offer is likely going to have to be over 15/16 quid here and its not a level the board will accept at this point. next year i think that that price will be more acceptable. not necessarily because the share price will be much lower at that time (i dont think they go much below 10 maybe to 950 but if they do then 8 is quite prob in that case) but the longer the share price is lower than the more pressure the board will be under to accept a price around 15/16. personally think its still a lot of money to pay inc of all debt so its only the americans that could be interested.
roguetraderuk
06/9/2022
08:12
Will be interesting if this firms up in the coming days, flush a comment out...?>
chrisdgb
06/9/2022
07:37
bid talk. some mention of it in the times. i noticed last week it was massively outperforming last week against weak global mkts and the volume has been spectacular the last few days. i would caution that it might just be some stake building by a fund because when it was at 12/13 quid i know some people were looking at it but with an eye to building a passive stake at 10 quid or less. eventually it think it gets done poss by the jnj arm post split, which is still some time off. but i could be wrong and given the weakness of sterling, its brought some interested parties out of the shadows.
roguetraderuk
05/9/2022
20:34
Interesting closing action….?
chrisdgb
25/8/2022
11:56
It cannot help in terms of investor confidence when in his first major public appearance he announces a profits warning and if I remember correctly the share fell by 10%.
1bearbull
25/8/2022
11:51
It is difficult to get excited when a Company has a CEO without any shareholding. Moreover, he can take up to 5 years or so to buy some. What is his incentive to get the share price up?
1bearbull
10/8/2022
00:15
Another day, another profits warning – but here's why you should stick by Smith & Nephew

Questor share tip: after another profits warning from the medical devices company, new boss Deepak Nath will need to get a grip

HOLD

philanderer
04/8/2022
14:38
What's this blue colour all about?
disc0dave45
04/8/2022
10:41
Perhaps £10 was the bottom - hope so.
Looking a bit better today.
Suet

suetballs
03/8/2022
22:10
A Chartist would agree that the sell off has indeed been over done, as per post below. I suspect bounce will be quicker than some other stocks as we all need medical supplies, more so than once upon a time when a career as a barber was a safe bet. Covid, long hair and beards have put oau to that certainty
hubshank
02/8/2022
12:57
Going to start to drip feed into these can't call bottom but feel that it will bounce back again.
csalvage
02/8/2022
11:08
Price drop may well be over done but looks like sub £10 could be soon.
Very unloved here and I can't see a catalyst for an upturn.
Investing isn't much fun atm.
Suet

suetballs
30/7/2022
18:24
in light of the price drop after earnings. The transcript of the earnings call is in the below link and also a recording of the call. personally I think the price drop is over done. In particular it is worth listening to the questions at the end. focus was made on this and i think good answers were given. www.seekingalpha.com/article/4527703-smith-and-nephew-plc-snn-ceo-deepak-nath-on-q2-2022-results-earnings-call-transcript
berny3
29/7/2022
21:00
I don't see any need to jump in, these could go lower, high p.e in my opinion.
montyhedge
29/7/2022
12:20
In case people missed the transaction from 23 May.
essentialinvestor
29/7/2022
12:19
Follow da leader ;


1. VESTING OF A CONDITIONAL AWARD GRANTED UNDER AN AWARD AGREEMENT DATED 29 APRIL 2022
On 23 May 2022, the Conditional Award of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested over 70,378 Shares. The resultant Shares post-vest were sold on 23 May 2022. Proceeds from the sale of sufficient Shares were utilised to satisfy the taxes due. As previously announced the Conditional Award formed part of buy-out awards in respect of outstanding incentives Deepak Nath forfeited upon leaving his former company.


Reason for the notification
Initial notification Initial notification
/Amendment
----------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
----------------------------------------------
LEI 213800ZTMDN8S67S1H61
----------------------------------------------
Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
Description of the Smith & Nephew plc ordinary shares of
financial instrument, USD 0.20 each
type of instrument
----------------------------------------------
Identification code ISIN: GB0009223206
----------------------------------------------
Nature of the transaction Vesting of a Conditional Award and subsequent
sale of all Shares .
----------------------------------------------
Date of Transaction 2022 - 05 - 23
----------------------------------------------
Place of Transaction London Stock Exchange (XLON)
---------------------------------

essentialinvestor
28/7/2022
15:59
Had this one on my radar for a while, waiting for a potentially suitable entry point. IMO it remains too pricey, all things considered. Really like the company in principle and the market they operate in long term seems extremely strong. Will keep watching from the sidelines. I might not get the chance, but not tempted at these levels anyway. GLA.
lovewinshatelosses
28/7/2022
15:12
I'm using their Melolin dressings atm following foot surgery, have to redress
every 2 day which is a right pain, luckily my better half works in healthcare.


If you are an optimist you might see today as kitchen sinking by the new CEO, perhaps.

essentialinvestor
28/7/2022
15:05
Shares are now HALF what they were pre pandemic. Sales will only increase moving forward and the Orthopaedic back log is huge. China adversely affected H1.
justiceforthemany
28/7/2022
15:03
EI that CEO sale was apparently forced - see IR response

The sales that were reported immediately followed receipt of a share award, that was made as part of buying out outstanding share awards from Deepak Nath's former company, that he had to forfeit upon leaving that company to join Smith+Nephew. It does not relate to any business developments.

Looking forward, the Chief Executive Officer is required to hold three times his salary in the form of shares, with a time of five years from his appointment to meet that requirement.

justiceforthemany
28/7/2022
13:51
jnj is prob no1 but only once they split which wont be happening for sometime. and re the price, yes here its not a bargain given the premium that needs to be paid. i dont think anyone is going to look at this in terms of m&a while abv 10 pounds. there are plenty of variables but i think buyers will want to be paying not a great deal abv current levels which means it would need to fall further to reflect a premium then.
roguetraderuk
28/7/2022
13:47
Surprised that no one commented on the large CEO share dump a few week back -

Those shares granted in lieu of the lapsed options in his previous role on
taking the SN position.

essentialinvestor
28/7/2022
13:44
£13/4 bn to take this out - plus their £2 bn approx in net debt.


Is SN. worth £15 bn...looks a stretch to me but never say never.


Stryker already carry a lump of debt, realistically only leaves JnJ imv.

essentialinvestor
28/7/2022
13:36
Will be taken over. Question of when not if.
justiceforthemany
28/7/2022
12:39
You read his posts?, seriously, really?.
essentialinvestor
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older

Your Recent History

Delayed Upgrade Clock